Pharmacogenomic Effect/ADR for Vortioxetine (DBSNPE004969)

Identifier
DBSNPE004969
Drug
Vortioxetine (DB09068)
Interacting Gene/Enzyme
Cytochrome P450 2D6
Gene Name
CYP2D6
UniProt ID
P10635
Defining Change(s)
-1426C>TNot Available
-1235A>GNot Available
-1000G>ANot Available
100C>TNot Available
310G>TNot Available
CYP2D7 sequence from intron 1 onwardsNot Available
Allele Name
CYP2D6*68A
Genotype(s)
Not Available
Type(s)
Effect Inferred
Groups
Non-functional CYP2D6
Description
Poor drug metabolizer, lower maximum dose.
References
  1. Trintellix (vortioxetine) tablets[package insert]. Deerfield, Illinois: Takeda Pharmaceuticals America, Inc. 2017. [Link]